TargetMol

Felodipine

Product Code:
 
TAR-T0145
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0145-5mg5mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-10mg10mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-1mL1 mL * 10 mM (in DMSO)£137.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-25mg25mg£172.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-50mg50mg£222.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-100mg100mg£294.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-200mg200mg£406.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0145-500mg500mg£618.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Felodipine is a longlasting 1, 4-dihydropyridine calcium channel repressor.
CAS:
72509-76-3
Formula:
C18H19Cl2NO4
Molecular Weight:
384.25
Pathway:
Membrane transporter/Ion channel; Metabolism; Autophagy
Purity:
0.9831
SMILES:
CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC
Target:
Calcium Channel; Autophagy

References

1. Johnson JD, et al. J Pharmacol Exp Ther, 1983, 226(2), 330-334. 2. R?dler S, et al. J Mol Cell Cardiol, 1995, 27(10), 2295-2302. 3. Yiu S, et al. J Med Chem, 1996, 39(23), 4576-4582. 4. Ding Y, et al. Hypertension, 1998, 32(4), 718-723. 5. Yang Z, et al. Cardiovasc Res, 2002, 53(1), 227-231.